Escherichia coli O157 interactions with human intestinal Caco-2 cells and the influence of fosfomycin

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 3, 1998, Pages 341-347

  Izumikawa, K ^a   Hirakata, Y ^a   Yamaguchi, T ^a   Takemura, H ^b   Maesaki, S ^a   Tomono, K ^a   Igimi, S ^c   Kaku, M ^b   Yamada, Y ^a   Kohno, S ^a   Kamihira, S ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FOSFOMYCIN; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; URINARY TRACT ANTIINFECTIVE AGENT; VEROTOXIN;

ARTICLE; BACTERIAL VIRULENCE; CELL INTERACTION; CELL STRAIN CACO 2; CONTROLLED STUDY; CULTURE MEDIUM; ESCHERICHIA COLI O157; GENE TRANSLOCATION; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; INTESTINE INFECTION; LEUKOCYTE; MONOLAYER CULTURE; NONHUMAN; SALMONELLA TYPHIMURIUM;

ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CYTOKINES; ESCHERICHIA COLI O157; FOSFOMYCIN; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MEMBRANE POTENTIALS; SHIGA-LIKE TOXIN I;

EID: 0031715730     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.3.341     Document Type: Article

References (37)

1. Infectious Agents Surveillance Center, National Institute of Health and Infectious Diseases Control Division, Ministry of Health and Welfare. (1997). Verocytotoxin-producing Escherichia coli (enterohaemorrhagic E. coli) infection. Infectious Agents Surveillance Report 18, 153-4.
2. Neumann, M. & Urizar, R. (1994). Hemolytic uremic syndrome: current pathophysiology and management. American Nephrology Nurses Association Journal 21, 137-43.
3. Karmali, M. A. (1989). Infection by verocytotoxin-producing Escherichia coli. Clinical Microbiology Reviews 2, 15-38.
4. O'Brien, A. D. & Holmes, R. K. (1987). Shiga and Shiga-like toxins. Microbiological Reviews 51, 206-20.
5. Obrig, T. G., Del Vecchio, P. J., Karmali, M. A., Petric, M., Moran, T. P. & Judge, T. K. (1987). Pathogenesis of haemolytic uraemic syndrome. Lancet ii, 687.
6. Gianviti, A., Rosmini, F., Caprioli, A., Corona, R., Matteucci, M. C., Principato, F. et al. (1994). Hemolytic-uraemic syndrome in childhood: surveillance and case-control studies in Italy. Italian HUS Study Group. Pediatric Nephrology 8, 705-9.
7. Cimolai, N., Basalyga, S., Mah, D. G., Morrison, B. J. & Carter, J. E. (1994). A continuing assessment of risk factors for the development of Escherichia coli O157:H7-associated hemolytic uremic syndrome. Clinical Nephrology 42, 85-9.
8. Begue, R. E., Neill, M. A., Papa, E. F. & Dennehy, P. H. (1994). A prospective study of Shiga-like toxin-associated diarrhea in a pediatric population. Journal of Pediatric Gastroenterology and Nutrition 19, 164-9.
9. Karmali, M. A., Petric, M., Lim, C., Fleming, P. C. & Steele, B. T. (1983). Escherichia coli cytotoxin, haemolytic-uraemic syndrome, and haemorrhagic colitis. Lancet ii, 1299-300.
10. Karmali, M. A., Petric, M., Lim, C., Fleming, P. C., Arbus, G. S. & Lior, H. (1985). The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. Journal of Infectious Diseases 151, 775-82.
11. Louise, C. B. & Obrig, T. G. (1991). Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in-vitro. Infection and Immunity 59, 4173-9.
12. Louise, C. B. & Obrig, T. G. (1992). Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of Shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infection and Immunity 60, 1536-43.
13. Tesh, V. L., Samuel, J. E., Perera, L. P., Sharefkin, J. B. & O'Brien, A. D. (1991). Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. Journal of Infectious Diseases 164, 344-52.
14. van de Kar, N. C., Monnens, L. A., Karmali, M. A. & van Hinsbergh, V. W. (1992). Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood 80, 2755-64.
15. van de Kar, N. C., Kooistra, T., Vermeer, M., Lesslauer, W., Monnens, L. A. & van Hinsbergh, V. W. (1995). Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C. Blood 85, 734-43.
16. Lopez, E. L., Contrini, M. M., Devoto, S., de Rosa, M. F., Grana, M. G., Genero, M. H. et al. (1995). Tumor necrosis factor concentrations in hemolytic uremic syndrome patients and children with bloody diarrhea in Argentina. Pediatric Infectious Disease Journal 14, 594-8.
17. Forsyth, K. D., Simpson, A. C., Fitzpatrick, M. M., Barratt, T. M. & Levinsky, R. J. (1989). Neutrophil-mediated endothelial injury in haemolytic uraemic syndrome. Lancet ii, 411-4.
18. Fitzpatrick, M. M., Shah, V., Filler, G., Dillon, M. J. & Barratt, T. M. (1992). Neutrophil activation in the hemolytic uremic syndrome: free and complexed elastase in plasma. Pediatric Nephrology 6, 50-3.
19. Fitzpatrick, M. M., Shah, V., Trompeter, R. S., Dillon, M. J. & Barratt, T. M. (1992). Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood. Kidney International 42, 951-6.
20. Salyers, A. A. & Whitt, D. D. (1994). Enterohemorrhagic E. coli (EHEC). In Bacterial Pathogenesis: a Molecular Approach, (Salyers, A. A. & Whitt, D. D., Eds), p. 194. American Society for Microbiology, Washington, DC.
21. Oelschlaeger, T. A., Barrett, T. J. & Kopecko, D. J. (1994). Some structures and processes of human epithelial cells involved in uptake of enterohemorrhagic Escherichia coli O157:H7 strains. Infection and Immunity 62, 5142-50.
22. Acheson, D. W., Moore, R., De Breucker, S., Lincicome, L., Jacewicz, M., Skutelsky, E. et al. (1996). Translocation of Shiga toxin across polarized intestinal cells in tissue culture. Infection and Immunity 64, 3294-300.
23. Finlay, B. B. & Falkow, S. (1990). Salmonella interactions with polarized human intestinal Caco-2 epithelial cells. Journal of Infectious Diseases 162, 1096-106.
24. Grasset, E., Pinto, M., Dussaulx, E., Zweibaum, A. & Desjeux, J. F. (1984). Epithelial properties of human colonic carcinoma cell line Caco-2: electrical parameters. American Journal of Physiology 247, C260-7.
25. Hughson, E. J., Cutler, D. F. & Hopkins, C. R. (1989). Basolateral secretion of kappa light chain in the polarised epithelial cell line, Caco-2. Journal of Cell Science 94, 327-32.
26. Dharmsathaphorn, K., McRoberts, J. A., Mandel, K. G., Tisdale, L. D. & Masui, H. (1984). A human colonic tumor cell line that maintains vectorial electrolyte transport. American Journal of Physiology 246, G204-8.
27. Walterspiel, J. N., Ashkenazi, S., Morrow, A. L. & Cleary, T. G. (1992). Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I. Infection 20, 25-9.
28. Tesh, V. L., Ramegowda, B. & Samuel, J. E. (1994). Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infection and Immunity 62, 5085-94.
29. Matsubara, Y., Tamizawa, I., Konishi, K., Hiraishi, H. & Ukai, S. (1975). Therapeutic effect of fosfomycin on bacillary dysentery and related enterocolitic infections. Kansenshogaku Zasshi [Journal of the Japanese Association for Infectious Diseases] 49, 843-55.
30. Takata, T., Tabata, M., Kanno, Y., Hirano, F. & Inoue, M. (1996). The effect of various antibacterial agents on the release of verotoxin against Escherichia coli O-157:H7 strains. Japanese Journal of Chemotherapy 45, 265-70.
31. Ito, T., Akino, E. & Hiramatsu, K. (1997). Evaluation of antibiotics used for enterohemorrhagic Escherichia coli O157 enteritis - effect of various antibiotics on extracellular release of verotoxin. Kansenshogaku Zasshi [Journal of the Japanese Association for Infectious Diseases] 71, 130-5.
32. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Testing for Bacteria that Grow Aerobically - Second Edition: Approved Standard. NCCLS, Villanova, PA.
33. Ramegowda, B. & Tesh, V. L. (1996). Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines. Infection and Immunity 64, 1173-80.
34. Inouye, S., Watanabe, T., Tsuruoka, T. & Kitasato, I. (1989). An increase in the antimicrobial activity in vitro of fosfomycin under anaerobic conditions. Journal of Antimicrobial Chemotherapy 24, 657-66.
35. Karpman, D., Andreasson, A., Thysell, H., Kaplan, B. S. & Svanborg, C. (1995). Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Pediatric Nephrology 9, 694-9.
36. van de Kar, N. C., Sauerwein, R. W., Demacker, P. N., Grau, G. E., van Hinsbergh, V. W. & Monnens, L. A. (1995). Plasma cytokine levels in hemolytic uremic syndrome. Nephron 71, 309-13.
37. Morikawa, K., Watabe, H., Araake, M. & Morikawa, S. (1996). Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrobial Agents and Chemotherapy 40, 1366-70.